In conclusion, our research shows that it is adequate to stimulate cytotoxicity T cell responses in mice by using HCC-specific antigen-GPC3 and IL-12 adjuvant recombinant Ad. The gene discussed is GPC3; the disease is hepatocellular carcinoma.